EUVIMEDEUVIMED entdecken
Crossref

Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular subtypes

MennatAllah Mohamed Hanafy, Rasha Mohamed Kamal, Sara Hassan Shams Alden Khater, Marina Mammdouh Gabrah Kirollus, Amr Farouk Ibrahim Moustafa

Annals of Nuclear Medicine · 2026

DOI: 10.1007/s12149-026-02234-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Nuclear Medicine, 2026. Verfasst von MennatAllah Mohamed Hanafy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Interventional Radiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. drmennamhanafy@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Positron-Emission Tomography, Mammography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: In the new era of nuclear breast imaging, differentiating benign from malignant uptake in the breast is essential in guiding clinical management. Accordingly, we aimed to assess the pattern of PEM uptake in benign and malignant breast lesions and to investigate its correlation with different histopathological subtypes, histological tumor grades, and molecular subtypes. METHODS: This was a prospective study comprised of 337 women with 465 breast lesions, of whom 128 patients had bilateral breast lesions. All patients performed Positron Emission Mammography (PEM) from March 2022 to February 2024. Any abnormality was evaluated qualitatively (mass and non-mass enhancement ) and quantitatively ( PUVmax and LTB ratio). The PEM readings were correlated with final pathology to differentiate benign from malignant lesions, and receiver operating characteristic (ROC) curve analysis was performed to assess the discriminant ability of PUVmax and LTB ratio in distinguishing histopathological groups, histological grades, and molecular subtypes. RESULTS: According to the final pathology, 330 (71%) lesions were malignant, and 135 (29%) were benign. The ROC curve analysis showed cutoff values of 1.92 and 3.145 for PUVmax and the LTB ratio, respectively, to discriminate between benign and malignant breast lesions. Significant differences in PUVmax and LTB ratio were detected between benign lesions and histopathological types, grades, and molecular malignant subtypes. The cutoff values for PUVmax and LTB ratio from benign were 1.81 and 3.165 for Ductal carcinoma in situ, 2.09 and 3.55 for invasive duct carcinoma (IDC) 1.62 and 2.8 for invasive lobular carcinoma,1.92 & 3.165 for grade I, 1.935 & 3.145 for grade II & III tumors, 1.92 and 3.145 for luminal molecular subtype, 1.95 and 3.45 for HER 2 subtype, and 2.28 and 4.27 for the triple-negative subtype respectively. The lesions with irregular shapes, uncircumscribed margins, and segmental non-mass distribution have higher PUVmax and LTB ratios. CONCLUSIONS: PEM is a valuable imaging modality for distinguishing between benign and malignant breast lesions. PEM may enable stratification of malignant lesions by histopathological subtype, tumour grade, and molecular subtypes. The highest metabolic activity was observed in invasive duct carcinoma, grade III, and the triple-negative molecular subtype. Overall, PEM can provide in vivo evaluation of breast lesion metabolic activity, leading to better lesion characterization and individualized patient management. However, due to methodological constraints, subgroup sample size, and radiation exposure, PEM should be regarded as an adjunct to sonomammography rather than a primary screening imaging modality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPositron-Emission TomographyMammographyHumansFemaleNeoplasm GradingMiddle AgedAdultAgedBiological TransportProspective Studies

Stichwörter der Autor:innen

Breast LesionsDuctal carcinoma in situInvasive ductal carcinomaInvasive lobular carcinomaLuminalPEMTriple negative

Autor:innen und Institutionen

  • Diagnostic and Interventional Radiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. drmennamhanafy@gmail.com.
  • Department of Radiology, Baheya Foundation for Early Detection and Treatment of Breast Cancer, Giza, Egypt. drmennamhanafy@gmail.com.
  • Diagnostic and Interventional Radiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Radiology, Baheya Foundation for Early Detection and Treatment of Breast Cancer, Giza, Egypt.
  • Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Suez General Hospital, Egyptian Ministry of Health, Suez, Egypt.

Zitieren

APA

Hanafy, M. M., Kamal, R. M., Khater, S. H. S. A., Kirollus, M. M. G., & Moustafa, A. F. I. (2026). Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular subtypes. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-026-02234-9

Vancouver

Hanafy MM, Kamal RM, Khater SHSA, Kirollus MMG, Moustafa AFI. Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular subtypes. Annals of Nuclear Medicine. 2026. doi:10.1007/s12149-026-02234-9

BibTeX
@article{Hanafy2026,
  author = {Hanafy, MennatAllah Mohamed and Kamal, Rasha Mohamed and Khater, Sara Hassan Shams Alden and Kirollus, Marina Mammdouh Gabrah and Moustafa, Amr Farouk Ibrahim},
  title = {Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular subtypes},
  journal = {Annals of Nuclear Medicine},
  year = {2026},
  doi = {10.1007/s12149-026-02234-9}
}
Kostenlos starten →